• Profile
Close

Measuring circulating complement activation products in myeloperoxidase and proteinase 3 antineutrophil cytoplasmic antibody vasculitis

Arthritis & Rheumatology Jun 24, 2019

Wu EY, et al. - Ninety-eight patients with ANCA vasculitis were included by the researchers in a case-control study in order to examine complement activation in MPO-ANCA and PR3-ANCA vasculitis post-ascertainment of the optimal methods for measurement of the activated complement factors in circulation. Higher levels of C5a and sC5b-9 were noted in active MPO-ANCA vasculitis and in remission. C3a and C4d were also noticed higher in remission. On comparing paired active and remission disease samples within patients, significant difference sC5b-9 were noted. Also, amongst patients in long-term remission off therapy C5a was significantly inferior. In comparison to futhan, patient samples processed without futhan had considerably higher median levels and individual values of Bb, C5a, and sC5b-9. Hence, the occurrence of complement activation both MPO-ANCA and PR3-ANCA vasculitis was observed. Further, the difference in the complement activation profile via disease activity and possibly ANCA serotype was noted. Furthermore, futhan decreased in vitro complement activation and presented a more accurate measurement. .
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay